tert-butyl (2S)-2-[[4-(dihexylamino)-1,1-dioxo-1,2,5-thiadiazol-3-yl]amino]-3-(4-hydroxyphenyl)propanoate → HCID 178444782、化合物
反応式
C([O:5][C:6](=[O:37])[C@H:7]([CH2:29][C:30]1[CH:35]=[CH:34][C:33]([OH:36])=[CH:32][CH:31]=1)[NH:8][C:9]1[C:13]([N:14]([CH2:21][CH2:22][CH2:23][CH2:24][CH2:25][CH3:26])[CH2:15][CH2:16][CH2:17][CH2:18][CH2:19][CH3:20])=[N:12][S:11](=[O:28])(=[O:27])[N:10]=1)(C)(C)C>C(O)=O>[CH2:15]([N:14]([C:13]1[C:9]([NH:8][C@H:7]([C:6]([OH:37])=[O:5])[CH2:29][C:30]2[CH:35]=[CH:34][C:33]([OH:36])=[CH:32][CH:31]=2)=[N:10][S:11](=[O:27])(=[O:28])[N:12]=1)[CH2:21][CH2:22][CH2:23][CH2:24][CH2:25][CH3:26])[CH2:16][CH2:17][CH2:18][CH2:19][CH3:20]参加物
3
実験手順
N-(4-(N,N-Di-n-hexylamino)-1,1-dioxo-1,2,5-thiadiazol-3-yl)-L-tyrosine tert-butyl ester (100 mg, 0.19 mmol) was dissolved in formic acid and the mixture stirred at room temperature for 36 hrs. Excess formic acid was removed under reduced pressure to yield N-(4-(N,N-Di-n-hexylamino)-1,1-dioxo-1,2,5-thiadiazol-3-yl)-L-tyrosine as a white solid (90 mg, 98%). Anal. Calc'd for C23H36N4O5S: C, 57.48; H, 7.55; N, 11.66. Found: C, 57.04; H, 7.23; N, 11.38.
後処理
- customExcess formic acid was removed under reduced pressure
出典と根拠
- ORDレコード
- ord-ad6abf92c21a464ebc73a05d4bd581b5
- 出典データセット
- uspto-grants-2002_11
- 特許番号
- US06479492B1
反応ノート
読み込み中…